G. Mychaskiw, V. Sachdev, B. Heath
May 1, 2001
Citations
1
Influential Citations
55
Citations
Quality indicators
Journal
Journal of clinical anesthesia
Abstract
Sildenafil is a selective phosphodiesterase type 5 inhibitor used in the treatment of erectile dysfunction. We report the use of sildenafil to blunt the rebound pulmonary hypertension seen following withdrawal of inhaled nitric oxide (NO) and milrinone. The relatively long duration of sildenafil's action on pulmonary artery pressures and lack of systemic hemodynamic effect make it an attractive option to facilitate weaning of inhaled NO.